Loading...
Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium
Randomised, double-blind, controlled trials are considered the gold standard for evaluating a pharmacological agent, as they minimise any potential bias. However, it is not always possible to perform double-blind trials, particularly for medications delivered via specific devices, e.g. inhalers. In...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3462669/ https://ncbi.nlm.nih.gov/pubmed/22726538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-13-52 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|